Meeder Asset Management Inc Ovid Therapeutics Inc. Transaction History

Meeder Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 05, 2019	SELL	$1.59 - $2.14 $1,138 - $1,532	-716 Closed	0 $0
Q4 2018 Jan 17, 2019	BUY	$2.42 - $6.6 $217 - $594	90 Added 14.38%	716 $2,000
Q3 2018 Nov 02, 2018	BUY	$5.6 - $11.0 $1,478 - $2,904	264 Added 72.93%	626 $0
Q2 2018 Jul 24, 2018	BUY	$6.16 - $10.14 $437 - $719	71 Added 24.4%	362 $0
Q1 2018 May 03, 2018	BUY	$6.53 - $9.82 $1,325 - $1,993	203 Added 230.68%	291 $2,000
Q4 2017 Feb 02, 2018	BUY	$6.12 - $12.31 $538 - $1,083	88	88 $1,000

39M

37.4K

500

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $73.2M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.